Analyst Consensus ?
ConsensusHold39 ratings
Bullish1948.7%
Neutral2051.3%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Healthpeak Properties, Inc. analyst ratings
Healthpeak Properties, Inc. (DOC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$18.84Current
$15Low
$20.96Average
$28High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 13, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Sep 21, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 13, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 11, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 10, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 6, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 15, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jun 11, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | May 27, 2026 |
| Argus Research | Hold | Buy | Downgrade | Feb 5, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 16, 2025 |
| Raymond James | Outperform | Market Perform | Upgrade | Sep 15, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Aug 20, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Apr 28, 2025 |
| B of A Securities | Buy | Underperform | Upgrade | Apr 1, 2024 |
| Keybanc | Overweight | Downgrade | Jan 5, 2024 | |
| Compass Point | Buy | Buy | Maintain | Jan 2, 2024 |
| Truist Securities | Hold | Hold | Maintain | Dec 22, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 28, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 4, 2022 |
| Berenberg | Buy | Hold | Upgrade | May 20, 2021 |
| B. Riley Securities | Buy | Buy | Maintain | May 7, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 22, 2020 |
| BTIG Research | Neutral | Buy | Downgrade | Mar 16, 2020 |
| BTIG | Neutral | Buy | Downgrade | Mar 15, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | Feb 27, 2020 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Nov 26, 2019 |
| Stifel | Buy | Hold | Upgrade | Nov 25, 2019 |
| Capital One Financial | Equal Weight | Overweight | Downgrade | May 2, 2019 |
| Capital One | Equal Weight | Overweight | Downgrade | May 1, 2019 |
| Bank of America | Buy | Buy | Maintain | Mar 8, 2018 |
| Hilliard Lyons | Buy | Long Term Buy | Maintain | Nov 5, 2017 |
| JMP Securities | Market Perform | Outperform | Downgrade | Jun 21, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 29, 2016 |
| Wunderlich | Buy | Buy | Maintain | May 21, 2014 |
| Wunderlich Securities | Buy | Buy | Maintain | May 20, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $18.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $20 | $18.82 | +6.2% | Oct 13, 2026 |
| Barclays | Richard Hightower | $21 | $18.95 | +11.5% | Oct 13, 2026 |
| Jefferies | Analyst unavailable | $21 | $20.37 | +11.5% | Sep 15, 2026 |
| Barclays | Analyst unavailable | $24 | $20.96 | +27.4% | Aug 31, 2026 |
| Cantor Fitzgerald | Richard Anderson | $23 | $21.52 | +22.1% | Aug 6, 2026 |
| Wells Fargo | Analyst unavailable | $22 | $21.66 | +16.8% | Jul 15, 2026 |
| Barclays | Analyst unavailable | $23 | $21.75 | +22.1% | Jul 7, 2026 |
| Mizuho Securities | Vikram Malhotra | $24 | $21.86 | +27.4% | Jul 6, 2026 |
| BMO Capital | Analyst unavailable | $24 | $20.69 | +27.4% | Jun 15, 2026 |
| Morgan Stanley | Ronald Kamdem | $22 | $20.76 | +16.8% | Jun 11, 2026 |
| Scotiabank | Analyst unavailable | $21 | $20.06 | +11.5% | May 27, 2026 |
| Morgan Stanley | Ronald Kamdem | $20 | $19.7 | +6.2% | May 22, 2026 |
| UBS | Analyst unavailable | $19 | $19.78 | +0.9% | May 13, 2026 |
| Morgan Stanley | Analyst unavailable | $18 | $15.83 | -4.4% | Apr 28, 2026 |
| UBS | Analyst unavailable | $17 | $17.37 | -9.7% | Apr 20, 2026 |
| Wells Fargo | John Kilichowski | $18 | $16.92 | -4.4% | Feb 3, 2026 |
| Goldman Sachs | Analyst unavailable | $17 | $17.04 | -9.7% | Jan 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $17 | $16.16 | -9.7% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $17 | $16.66 | -9.7% | Dec 15, 2025 |
| Evercore ISI | Analyst unavailable | $21 | $16.8 | +11.5% | Dec 15, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $20 | $19.15 | +6.2% | Oct 1, 2025 |
| Evercore ISI | Analyst unavailable | $22 | $18.08 | +16.8% | Sep 15, 2025 |
| Raymond James | Jonathan Hughes | $20 | $18.25 | +6.2% | Sep 15, 2025 |
| Morgan Stanley | Analyst unavailable | $21 | $17.75 | +11.5% | Aug 22, 2025 |
| Robert W. Baird | Analyst unavailable | $21 | $17.22 | +11.5% | Jul 30, 2025 |
| Deutsche Bank | Omotayo Okusanya | $28 | $22.64 | +48.7% | Oct 21, 2024 |
| Citigroup | Nick Joseph | $22 | $21.89 | +16.8% | Aug 21, 2024 |
| Robert W. Baird | Wesley Golladay | $24 | $21.85 | +27.4% | Jul 30, 2024 |
| RBC Capital | Michael Carroll | $25 | $21.85 | +32.7% | Jul 30, 2024 |
| Wedbush | Richard Anderson | $22 | $19.17 | +16.8% | May 3, 2024 |
| RBC Capital | Michael Carroll | $22 | $19.34 | +16.8% | Apr 10, 2024 |
| Robert W. Baird | Analyst unavailable | $22 | $18.31 | +16.8% | Mar 27, 2024 |
| Wells Fargo | Connor Siversky | $19 | $17.54 | +0.9% | Mar 25, 2024 |
| Credit Suisse | Omotayo Okusanya | $15 | $14.64 | -20.4% | Aug 1, 2023 |
| Morgan Stanley | Analyst unavailable | $16.5 | $16.95 | -12.4% | Aug 31, 2022 |
| Morgan Stanley | Analyst unavailable | $16 | $16.76 | -15.1% | Jul 15, 2022 |
| Truist Financial | Analyst unavailable | $17 | $16.58 | -9.7% | Jul 11, 2022 |
| Jefferies | Analyst unavailable | $20 | $17.58 | +6.2% | Jun 30, 2022 |
| Morgan Stanley | Analyst unavailable | $17.5 | $18.55 | -7.1% | Jun 1, 2022 |
| Barclays | Analyst unavailable | $20 | $17.58 | +6.2% | Apr 26, 2022 |
| Truist Financial | Michael R Lewis | $19 | $17.26 | +0.9% | May 6, 2021 |
Track every rating change on DOC the moment it posts. Free to start.
Start freeGet the DOC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.